OpenAI has confirmed a partnership with Color Health to create an AI assistant that assists doctors in developing personalized cancer screening and customized treatment plans, significantly reducing delays in care. The Color Health AI assistant, based on GPT-4o, will identify missing diagnoses to help healthcare providers make evidence-based decisions. Tests have shown that doctors using the AI assistant identified four times more missing laboratory tests and screenings compared to those who did not use the assistant. Color plans to provide AI-generated screening plans for over 200,000 patients by the end of this year. Making cancer expertise accessible Since 2013, the healthcare provider has been collaborating with OpenAI to improve cancer patient care by reviewing inconsistent patient data formats, analyzing comprehensive healthcare guidelines, and ensuring patient data privacy. The company is able to leverage OpenAI's Chat GPT-4 and GPT-4o models to perform complex tasks, such as extracting key data from detailed PDFs that contain complex charts and specific care pathways. GPT-4 Vision has demonstrated proficiency in interpreting these complex charts. Othman Laraki, CEO of Color Health, said, "Color's vision is to make cancer expertise accessible at the time and place where it has the greatest impact on patient medical decisions." He continued, "As a healthcare company, technology that improves access and equity must go hand in hand with technology that supports patient safety and privacy. OpenAI's HIPAA-compliant data protection standards are crucial." For cancer patients and the professionals responsible for their care, every hour and every day is crucial, and every delay comes at a high cost. Patients whose treatment is delayed by just four weeks face a 6-13% higher mortality rate, highlighting the significant impact that Color's AI assistant and close collaboration with OpenAI can have on the lives of those who need it most.